Search

A novel photodegradable polyethylene-oxidized polyethylene wax-TiOz (PE-OPW-TiO 2 ) nanocomposite film was prepared by embedding the organically modified TiO 2 nanoparticles into commercial PE in the presence of OPW. The photocatalytic degradation behavior under ultraviolet light or solar light was investigated by examining the weight loss of the composite films, UV-vis transmittance spectrum, scanning electron microscope (SEM), and gel permeation chromatogram (GPC). The results show that OPW, as a dispersant and a compatibiliser, markedly improves the dispersion and compatibility of TiO 2 nanoparticles in PE resins. The PE-OPW-TiO 2 composite film demonstrates much higher photodegradation efficiency and much better mechanical property than either the PE-TiO 2 composite film or the pure PE film. The weight-average molecular weight (M w ) of the PE-OPW-TiO 2 composite film decreased 94.3% and the number-average molecular weight (M n ) decreased 84.5% after 38 days solar light irradiation. The photocatalytic degradation mechanism of the film is briefly discussed.

Forty-one cloud-free images of Qinghai Lake (QHL) in China and the corresponding digital numbers (DNs) of FengYun-2C (FY-2C) at 0000, 0600, 1200, and 1800 UTC from 1 July to 30 September 2005 are analyzed. The corresponding surface water temperatures of QHL measured by the automated hydrometeorological buoy (AHMB) system and the atmospheric profiles over QHL from the National Centers for Environmental Prediction (NCEP) reanalysis data are inputted into the atmospheric transfer model MODTRAN3.7 to calculate the entrance pupil radiance and brightness temperatures for thermal infrared (TIR) channels of FY-2C. Then, the absolute radiometric calibration coefficients of FY-2C, which are used to calculate the equivalent blackbody (EBB) temperatures TEBB, are calculated by comparing the entrance pupil radiance and brightness temperatures with the corresponding DNs. In addition, the temperatures of onboard blackbody (OBB) TOBB, primary, secondary, refraction, and calibration mirrors on the multichannel scanning radiometer (MSR) of FY-2C are detected remotely. Based on the linear correlation between TEBB − TOBB and temperatures of various mirrors, the transform equations from TOBB to TEBB are developed. Finally, the onboard real-time absolute radiometric calibration for TIR channels of geostationary meteorological satellite FY-2C is implemented with an uncertainty of about 1.5 and 2.1 K for TIR 1 and TIR 2 of FY-2C, respectively.

The titled complex has been synthesized according to the template method from the prepared intermediate of 2,3-dicyano-5-methyl-1,4-dithiin in the presence of iron(II)sulfate heptahydrate and characterized by UV–vis, FT-IR , 1H NMR, XPS and elemental analysis. The complex was supported on an Amberlite CG-400 resin to form a biomimetic catalyst, the ability of which for activating molecular oxygen was estimated from the degradation of Rhodamine B (RhB) under visible light irradiation in an aerated suspension. About 78% of the RhB was degraded in 27 h with a rate constant of 1.84 × 10−10 mol L−1 s−1. Aggregation between the dimer and monomer for the titled complex in DMSO or in DMF solution was observed from the concentration dependence in the UV–vis spectra. The effect of the aggregation was also demonstrated by the diffuse reflectance spectral measurement for the catalyst supported on the resin in saturated and supersaturated adsorption conditions. The monomer of catalyst has a higher capability to activate molecular oxygen for the degradation of organic pollutants than that of an aggregation form.

In order to separate the main individual theaflavin monomers from black tea, high-speed countercurrent chromatography (HSCCC) and Sephadex LH-20 column chromatography were applied. The results showed that theaflavin (TF1), theaflavin-3-gallate (TF2A), theaflavin-3'-gallate (TF2B) and theaflavin-3,3'-digallate (TF3) can be obtained by HSCCC using a solvent system composed of n-hexane-ethyl acetate-methanol-water (1:3:1:6, v/v/v/v), but the TF1 was containing epicatechin-3-gallate (ECG). Similarly, Sephadex LH-20 can also effectively separate TF2A(B) and TF3, but epigallocatechin-3-gallate (EGCG) contaminated TF1, too. Combination of HSCCC and Sephadex LH-20, the preferably purified TF1, TF2A(B) and TF3 were obtained than single separation technique. In addition, ECG and EGCG were also suggested to be able to be comprehensively separated by combination of the two techniques.

Adropin is a peptide encoded by the energy homeostasis associated gene (Enho) and plays a critical role in the regulation of lipid metabolism, insulin sensitivity, and endothelial function. Little is known of the effects of adropin in the brain and whether this peptide modulates ischemia-induced blood-brain barrier (BBB) injury. Here, we used an in vitro BBB model of rat brain microvascular endothelial cells (RBE4) and hypothesized that adropin would reduce endothelial permeability during ischemic conditions. To mimic ischemic conditions in vitro, RBE4 cell monolayers were subjected to 16h hypoxia/low glucose (HLG). This resulted in a significant increase in paracellular permeability to FITC-labeled dextran (40kDa), a dramatic upregulation of vascular endothelial growth factor (VEGF), and the loss of junction proteins occludin and VE-cadherin. Notably, HLG also significantly decreased Enho expression and adropin levels. Treatment of RBE4 cells with synthetic adropin (1, 10 and 100ng/ml) concentration-dependently reduced endothelial permeability after HLG, but this was not mediated through protection to junction proteins or through reduced levels of VEGF. We found that HLG dramatically increased myosin light chain 2 (MLC2) phosphorylation in RBE4 cells, which was significantly reduced by adropin treatment. We also found that HLG significantly increased Rho-associated kinase (ROCK) activity, a critical upstream effector of MLC2 phosphorylation, and that adropin treatment attenuated that effect. These data indicate that treatment with adropin reduces endothelial cell permeability after HLG insult by inhibition of the ROCK-MLC2 signaling pathway. These promising findings suggest that adropin protects against endothelial barrier dysfunction during ischemic conditions.

Cyclooxygenase-2 (COX-2) is activated in response to ischemia and significantly contributes to the neuroinflammatory process. Accumulation of COX-2-derived prostaglandin E2 (PGE2) parallels the substantial increase in stroke-mediated blood-brain barrier (BBB) breakdown. Disruption of the BBB is a serious consequence of ischemic stroke and is mainly mediated by matrix metalloproteinases (MMPs). This study aimed to investigate the role of PGE2 EP1 receptor in neurovascular injury in stroke. We hypothesized that pharmacological blockade or genetic deletion of EP1 protects against BBB damage and hemorrhagic transformation by decreasing the levels and activity of MMP-3 and MMP-9. We found that post-ischemic treatment with the EP1 antagonist, SC-51089, or EP1 genetic deletion results in a significant reduction in BBB disruption and reduced hemorrhagic transformation in an experimental model of transient focal cerebral ischemia. These neurovascular protective effects of EP1 inactivation are associated with a significant reduction in MMP-9/-3, less peripheral neutrophil infiltration and a preservation of tight junction proteins (ZO-1 and occludin) composing the BBB. Our study identifies the EP1 signaling pathway as an important link between neuroinflammation and MMP-mediated BBB breakdown in ischemic stroke. Targeting the EP1 receptor could represent a novel approach to diminish the devastating consequences of stroke-induced neurovascular damage.

At 1.0–4.0 GPa and 11213–1473 K and under oxygen fugacity-controlled conditions (Bi + NiO, Fe + Fe3O4, Fe + FeO and Mo + MoO2 buffers), a YJ-3000t Model six-anvil solid high-pressure apparatus and a Sarltron-1260 Impedance/Gain-Phase analyzer were employed to conduct an in situ measurement of the electrical conductivity of single crystal olivine. Experimental results showed that: (1) within the range of experimentally selected frequencies (103–106 Hz), the electrical conductivity of the sample is of great dependence on the frequency; (2) with the rise of temperature (T); the electrical conductivity (σ) will increase, and the Arrenhius linear relationship is established between 1gσ and 1/T; (3) under the control of oxygen buffer Fe + Fe3O4, with the rise of pressure, the electrical conductivity tends to decrease whereas the activation enthalpy and independent-of-temperature preexponential factor tend to increase, with the activation energy and activation volume of the sample estimated at (1.25 + 0...

An anion-resin carrying the catalyst iron(II) tetra(1,4-dithin)porphyrazine, ( Fe (II) Pz ( dtn )4/resin), may effectively interact with the lone-pair electron of the sulfur in the Fe (II) Pz ( dtn )4 to keep the absorption for the catalyst molecule, which can efficiently activate molecular oxygen coordinated with iron(II) on the axial orientation of Fe (II) Pz ( dtn )4 through electron transfer in a heterogeneous process. On the other hand, the hydrophilic property of the resin also facilitates adsorption of the anion-substrates in the aqueous solution onto the unoccupied resin surface to increase the substrate concentration around the Fe (II) Pz ( dtn )4 and the contact probability between the substrate with activated molecular oxygen to promote the oxidative degradation of these adsorbed substrates. The stability and repeatability of the Fe (II) Pz ( dtn )4/resin were determined by some control experiments. The results indicate that Fe (II) Pz ( dtn )4 was stable enough in the presence of active oxygen species under irradiation of visible light and could degrade recalcitrant organic pollutants such as rhodamine B and p-nitrobenzoic acid. It can be reused at least 5 cycling runs without losing activity.

Activation of the prostacyclin (PGI2) IP receptor is protective in brain ischemia. However, there is very limited information of the molecular mechanisms of protection and the feasibility to target this pathway in stroke. MRE-269, a highly selective PGI2/IP receptor agonist, has been recently discovered. This IP agonist has a long half-life in vivo and is currently in phase III clinical trials for pulmonary hypertension. We hypothesized that post-ischemic treatment with MRE-269 provides neuroprotection in a rat ischemic stroke model. Young male rats (3-4-month old) were subjected to middle cerebral artery occlusion (MCAO) for 90 min and treated intravenously with either vehicle (n=14) or MRE-269 (0.1, 0.25, 0.5, and 1 mg/kg, n=10-14/group) at the start of reperfusion. At 48 h post-MCAO, rats were sacrificed to determine infarct size, blood-brain barrier (BBB) damage (IgG extravasation), hemorrhagic transformation (brain hemoglobin levels), and matrix metalloproteinase (MMP)-9 activity. In a separate experiment, aged male rats (18-20-month old) underwent 90 min of MCAO and randomly selected to receive intravenously either vehicle (n=11) or MRE-269 (0.25 mg/kg, n=11) starting at 4.5 h post-MCAO. Additional doses were given every 12 h for the first 48 h, and then one injection daily for 7 days post-MCAO. The accelerating rotarod and the adhesive removal tests were conducted before and at 3, 7, 14 and 21 days after MCAO by an investigator blinded to treatment groups. Infarct volume was quantified by MRI at 48 h and 21 days post-MCAO. In young rats, MRE-269 dose-dependently reduced cortical infarct size. MRE-269-treated rats (0.25 mg/kg) had significantly reduced BBB damage and less hemorrhagic transformation. Compared with the vehicle group, MRE-269-treated animals showed a significant reduction in brain MMP-9 activity. In aged rats, MRE-269 treatment resulted in a significant long-term recovery in both locomotor and somatosensory functions following MCAO. Quantitative MRI data showed that MRE-269 significantly reduced infarct volume compared with vehicle-treated rats. Our data suggest that targeting the PGI2/IP receptor with MRE-269 is a novel strategy to reduce neurovascular injury and promote long-term neurological recovery in ischemic stroke.

Epoxidation of olefins with H2O2 is one of the most important reactions in organic synthesis. We found that anatase TiO2 can be a good catalyst for the epoxidation of cyclooctene with H2O2 at room temperature. However, the catalyst deactivated quickly in the presence of excess amount of H2O2 because of the formation of inactive side-on Ti-η(2)-peroxide species on the surface of TiO2, the presence of which was confirmed by isotope-labelled resonance UV Raman spectroscopy and kinetics studies. Interestingly, the epoxidation reaction could be dramatically accelerated under irradiation of UV light with λ≥350 nm. This phenomenon is attributed to the photo-assisted removal of the inactive peroxide species, through which the active sites on the surface of anatase TiO2 are regenerated and the catalytic epoxidation of cyclooctene with H2O2 is resumed. This finding provides an alternative for sustained epoxidation reactions on TiO2 at room temperature. Moreover, it also has significant implications on the deactivation pathway and possible solutions in Ti-based heterogeneous catalysis or photocatalysis.

Aims The role of endothelial nitric oxide synthase (eNOS)/NO signalling is well documented in late ischaemic preconditioning (IPC); however, the role of eNOS and its activation in early IPC remains controversial. This study investigates the role of eNOS in early IPC and the signalling pathways and molecular interactions that regulate eNOS activation during early IPC. Methods and results Rat hearts were subjected to 30-min global ischaemia and reperfusion (I/R) with or without IPC (three cycles 5-min I and 5-min R) in the presence or absence of the NOS inhibitor l-NAME, phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002 (LY), and protein kinase A (PKA) inhibitor H89 during IPC induction or prior endothelial permeablization. IPC improved post-ischaemic contractile function and reduced infarction compared with I/R with this being abrogated by l-NAME or endothelial permeablization. eNOSSer1176, AktSer473, and PKAThr197 phosphorylation was increased following IPC. I/R decreased eNOSSer1176 phosphorylation, whereas IPC increased it. Mass spectroscopy confirmed eNOSSer1176 phosphorylation and quantitative Western blots showed ∼24% modification of eNOSSer1176 following IPC. Immunoprecipitation demonstrated eNOS, Akt, and PKA complexation. Immunohistology showed IPC-induced Akt and PKA phosphorylation in cardiomyocytes and endothelium. With eNOS activation, IPC increased NO production as measured by electron paramagnetic resonance spin trapping and fluorescence microscopy. LY or H89 not only decreased AktSer473 or PKAThr197 phosphorylation, respectively, but also abolished IPC-induced preservation of eNOS and eNOSSer1176 phosphorylation as well as cardioprotection. Conclusion Thus, Akt- and PKA-mediated eNOS activation, with phosphorylation near the C-terminus, is critical for early IPC-induced cardioprotection, with eNOS-derived NO from the endothelium serving a critical role.

Ischemia (I)/reperfusion (RP)-induced endothelial cell (EC) injury is thought to occur due to mitochondrial reactive oxygen species (mtROS) production. MtROS have been implicated in mitochondrial fission. We determined whether cultured EC exposure to simulated I/RP causes morphological changes in the mitochondrial network, and the mechanisms behind those changes. Since shear stress results in nitric oxide (NO)-mediated endothelial mtROS generation, we simulated I/RP as hypoxia (H) followed by oxygenated flow over the ECs (shear stress of 10 dyne/cm2). By exposing ECs to shear stress, H, H/reoxygenation (RO) or simulated I/RP and employing mitotracker staining, the differential effects of changes in mechanical forces and/or O2 levels on the mitochondrial network were assessed. Static or sheared ECs maintained their mitochondrial network. H- or H/RO-exposed ECs underwent changes, but mitochondrial fission was significantly less compared to that in ECs exposed to I/RP. I/RP-induced fission was partially inhibited by antioxidants, a NO synthase inhibitor or an inhibitor of the fission protein dynamin-related protein 1 (Drp1), and was accompanied by Drp1 oligomerization and phosphorylation (Ser616). Hence, shear-induced NO, ROS (including mtROS), and Drp1 activation are responsible for mitochondrial fission in I/RP-exposed ECs, and excessive fission may be an underlying cause of EC dysfunction in postischemic hearts.

In this paper, a novel kind of photodegradable PVC-FePcCl(16) composite film was prepared by homogeneous embedding FePcCl(16) into the commercial PVC plastic. The photodegradation performance of as-prepared film has been investigated in the ambient air under UV light irradiation by means of weight loss monitoring, FT-IR spectroscopy, UV-Vis spectroscopy. In comparison with the pure PVC film, higher weight loss rate, increasing carbonyl peak intensity and accelerating dehydrochlorination were observed. These results indicate that the PVC-FePcCl(16) composite film has a higher photodegradation activity owing to the FePcCl(16). Moreover, FePcCl(16) has good photostability in the photoreaction. The possible photodegradation mechanism of PVC-FePcCl(16) composite film was also discussed.

A novel photodegradable polyvinyl chloride (PVC)-vitamin C (VC)-TiO(2) nano-composite film was prepared by embedding VC modified nano-TiO(2) photocatalyst into the commercial PVC plastic. The solid-phase photocatalytic degradation behavior of PVC-VC-TiO(2) nano-composite film under UV light irradiation was investigated and compared with those of the PVC-TiO(2) film and the pure PVC film, with the aid of UV-Vis spectroscopy, scanning electron microscopy (SEM), weight loss monitoring, and X-ray diffraction spectra (XRD). The results show that PVC-VC-TiO(2) nano-composite film has a high photocatalytic activity; the photocatalytic degradation rate of it is two times higher than that of PVC-TiO(2) film and fifteen times higher than that of pure PVC film. The optimal mass ratio of VC to TiO(2) is found to be 0.5. The mechanism of enhancing photocatalytic activity is attributed to the formation of a Ti(IV)-VC charge-transfer complex with five-member chelate ring structure and a rapid photogenerated charge separation is thus achieved.

It is known that the Na/K-ATPase alpha1 subunit interacts directly with inositol 1,4,5-triphosphate (IP(3)) receptors. In this study we tested whether this interaction is required for extracellular stimuli to efficiently regulate endoplasmic reticulum (ER) Ca(2+) release. Using cultured pig kidney LLC-PK1 cells as a model, we demonstrated that graded knockdown of the cellular Na/K-ATPase alpha1 subunit resulted in a parallel attenuation of ATP-induced ER Ca(2+) release. When the knockdown cells were rescued by knocking in a rat alpha1, the expression of rat alpha1 restored not only the cellular Na/K-ATPase but also ATP-induced ER Ca(2+) release. Mechanistically, this defect in ATP-induced ER Ca(2+) release was neither due to the changes in the amount or the function of cellular IP(3) and P2Y receptors nor the ER Ca(2+) content. However, the alpha1 knockdown did redistribute cellular IP(3) receptors. The pool of IP(3) receptors that resided close to the plasma membrane was abolished. Because changes in the plasma membrane proximity could reduce the efficiency of signal transmission from P2Y receptors to the ER, we further determined the dose-dependent effects of ATP on protein kinase Cepsilon activation and ER Ca(2+) release. The data showed that the alpha1 knockdown de-sensitized the ATP-induced ER Ca(2+) release but not PKCepsilon activation. Moreover, expression of the N terminus of Na/K-ATPase alpha1 subunit not only disrupted the formation of the Na/K-ATPase-IP(3) receptor complex but also abolished the ATP-induced Ca(2+) release. Finally, we observed that the alpha1 knockdown was also effective in attenuating ER Ca(2+) release provoked by angiotensin II and epidermal growth factor.

In order to separate the main individual theaflavin monomers from black tea, high-speed countercurrent chromatography (HSCCC) and Sephadex LH-20 column chromatography were applied. The results showed that theaflavin (TF1), theaflavin-3-gallate (TF2A), theaflavin-3'-gallate (TF2B) and theaflavin-3,3'-digallate (TF3) can be obtained by HSCCC using a solvent system composed of n-hexane-ethyl acetate-methanol-water (1:3:1:6, v/v/v/v), but the TF1 was containing epicatechin-3-gallate (ECG). Similarly, Sephadex LH-20 can also effectively separate TF2A(B) and TF3, but epigallocatechin-3-gallate (EGCG) contaminated TF1, too. Combination of HSCCC and Sephadex LH-20, the preferably purified TF1, TF2A(B) and TF3 were obtained than single separation technique. In addition, ECG and EGCG were also suggested to be able to be comprehensively separated by combination of the two techniques.

Because ouabain activates several pathways that are critical to cardioprotective mechanisms such as ischemic preconditioning, we tested if this digitalis compound could protect the heart against ischemia-reperfusion injury through activation of the Na+,K+-ATPase/c-Src receptor complex.In Langendorff-perfused rat hearts, a short (4 min) administration of ouabain 10 muM followed by an 8-minute washout before 30 min of global ischemia and reperfusion improved cardiac function, decreased lactate dehydrogenase release and reduced infarct size by 40%. Western blot analysis revealed that ouabain activated the cardioprotective phospholipase Cgamma1/protein kinase Cepsilon (PLC-gamma1/PKCepsilon) pathway. Pre-treatment of the hearts with the Src kinase family inhibitor 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolol[3,4-d]pyrimidine (PP2) blocked not only ouabain-induced activation of PLC-gamma1/PKCepsilon pathway, but also cardiac protection. This protection was also blocked by a PKCepsilon translocation inhibitor peptide (PKCepsilon TIP).Short exposure to a low concentration of ouabain protects the heart against ischemia/reperfusion injury. This effect of ouabain on the heart is most likely due to the activation of the Na+,K+-ATPase/c-Src receptor complex and subsequent stimulation of key mediators of preconditioning, namely PLC-gamma1 and PKCepsilon.

Background Matrix metalloproteinases are important factors in the molecular mechanisms leading to neuronal injury in many neurological disorders. Matrix metalloproteinase (MMP)-9 is up-regulated after cerebral ischemia and neuroinflammation and is actively involved in blood–brain barrier disruption. Current methods of measuring MMP-9 activity, such as gelatin-substrate zymography, are unspecific and arduous. Here we developed an immunocapture assay with high efficiency, specificity, and sensitivity for quantifying endogenously active as well as total MMP-9 activity. Results A fluorescence resonance energy transfer (FRET) peptide-based immunocapture assay was developed that enables the accurate assessment of total and active forms of MMP-9 in complex biological samples. The FRET assay demonstrated correct and efficient binding of MMP-9 to a mouse monoclonal MMP-9 antibody and high specificity of the immunocapture antibody for MMP-9. Total and active levels of MMP-9 were measured in rat brain homogenates, plasma, human HT-1080 conditioned media, and RBE4 endothelial cell lysates. The FRET immunocapture assay yielded highly similar results for total MMP-9 activity when compared to gelatin-substrate zymography. Conclusions We suggest that the new FRET peptide-based immunocapture assay is a viable replacement of zymography for sensitive and high throughput quantification of MMP-9 activity in biological samples.